Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305 GBX | -5.57% | -3.17% | -13.48% |
Apr. 02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
Apr. 02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.48% | 419M | |
+7.06% | 219B | |
+7.57% | 187B | |
+11.79% | 134B | |
+27.18% | 101B | |
+0.30% | 62.27B | |
+16.01% | 52.82B | |
-1.63% | 47.49B | |
-1.38% | 40.79B | |
+11.83% | 39.35B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MaxCyte Says CFO Murphy Leaving Company; Preliminary Q1 Revenue Ahead of Estimates